Coronaviruses (CoV) are common throughout the world and are part of a large family of viruses that cause illnesses ranging from the common cold to the Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Today we are faced with COVID-19 which is rapidly spreading itself globally.
The potential global health risk posed by COVID-19 is extremely high as the influenza-like illness ranges from mild symptoms to severe illness and possible death. Current confirmed cases are seeing prolific growth daily and CDC recommendations for infection prevention and control is evolving quickly.
As we strive to better understand SARS-CoV-2 and look forward to providing developers and laboratories with safe to use, non-infectious external quality controls, we recommend a review of our current Coronavirus products which may provide some utility in your assay development and/or research and analytical studies.
| Virus | Characterization | Product Number | Product Description |
BSL Level |
Additional Information |
| SARS-CoV-2 | Influenza A: A/Brisbane/10/07 ,Influenza B: B/Florida/02/06 , RSVB: CH93(18)-18 , SARS-COV-2: USA-WA1/2020 | NATFRC-6C |
NATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL) |
|
Non-Infectious, Intact Viral Particle Quality Control. |
| NATCV9-6C | NATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL) | Non-Infectious, Intact Viral Particle Quality Control. | |||
| NATRPC2.1-BIO | NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) | Non-Infectious, Intact Viral Particle Quality Control. | |||
| NATRVP2.1-BIO | NATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA) | Non-Infectious, Intact Viral Particle Quality Control. | |||
| NATRVP2-QIA | NATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA) | Non-Infectious, Intact Viral Particle Quality Control. | |||
| Alpha (B.1.1.7); Beta (B.1.351); Delta (B.1.617.2); Gamma P.1) | NATSARS(COV2)-VP | NATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL) | Non-Infectious, Intact Viral Particle Quality Control. | ||
| USA-WA1/2020 | NATSARS(COV2)-ERC | SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL) | Non-Infectious, Intact Viral Particle Quality Control. | ||
| A-549 | NATSARS(COV2)-NEG | SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL) | Non-Infectious, Human A549 Cells, Quality Control. | ||
| USA-WA1/2020 |
SARS-Related Coronavirus 2 (SARS-CoV-2) Stock |
|
Non-Infectious, Intact Viral Particles Quality Control. |
||
| B.1.351 | NATSARS(COV2-SA)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| B.1.1.7 | NATSARS(COV2-UK)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| USA-WA1/2020 | 0810587 | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg) | BSL2 | Purified, Disrupted and Heat Inactivated. | |
| USA-WA1/2020 | 0810587-0.5mg | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg) | BSL2 | Purified, Disrupted and Heat Inactivated. | |
| USA-WA1/2020 | 0810587CFHI-0.5mL | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| USA-WA1/2020 | 0810587CFHI | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| USA-WA1/2020 | 0810587UV | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.617.1 Kappa | 0810623UV | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.617.1 Kappa | 0810623CFHI | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| B.1.617.2 Delta | 0810624UV | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.617.2 Delta | 0810624CFHI | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| Italy-INMI1 | 0810589CFHI | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| Italy-INMI1 | 0810589UV | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| Hong Kong/VM20001061/2020 | 0810590CFHI | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
|
Hong Kong/VM20001061/2020 |
0810590UV | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
|
|
0810612CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| B.1.1.7 | 0810612UV | SARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.351 | 0810613CFHI | SARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
|
B.1.351 |
0810613UV | SARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
|
B.1.1.7 |
0810614CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| B.1.1.7 | 0810614UV | SARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| P1 | 0810616CFHI | SARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| P1 | 0810616UV | SARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| 0820010CFHI | VeroE6 Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | ||
| SARS-CoV-2 Recombinant | 0831042 | SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL) | BSL2 | Inactivated, Intact Bacterial Cells containing synthetic SARS-CoV-2 sequence. Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 N gene. | |
| 0831043 | SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x 1.0mL) | BSL2 | Inactivated, Intact Bacterial Cells containing synthetic SARS-CoV-2 sequence. Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 E gene and portions of the ORF1ab gene region. | ||
| SARS | 2003-00592 | NATSARS-ST | Coronavirus SARS Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | |
| Coronavirus | 229E | NATCOV(229E)-ST | Coronavirus 229E Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | |
| 229E |
Coronavirus Strain: 229E Culture Fluid |
BSL2 | Titered Live Material MTA Required. |
||
| 229E | Coronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 |
Heat Inactivated Viral Culture Fluid.
|
||
| 229E | 0810229 | Coronavirus Strain: 229E Lysate | BSL2 | Purified, Disrupted and Heat Inactivated. | |
| NL63 | NATCOV(NL63)-ST | Coronavirus NL63 Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| NL63 |
Coronavirus Strain: NL63 Culture Fluid |
BSL2 |
Titered Live Material MTA Required. |
||
| NL63 | Coronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL) |
BSL2 |
Heat Inactivated Viral Culture Fluid. |
||
| NL63 |
Coronavirus Strain: NL63 Lysate |
BSL2 |
Purified, Disrupted and Heat Inactivated. |
||
| OC43 | NATCOV(OC43)-ST | Coronavirus OC43 Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| OC43 |
Coronavirus Strain: OC43 Culture Fluid
|
BSL2 | Titered Live Material MTA Required. |
||
| OC43 |
|
Coronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL) |
BSL2 |
Heat Inactivated Viral Culture Fluid.
|
|
| OC43 | 0810024 | Coronavirus Strain: OC43 Lysate | BSL2 | Purified, Disrupted and Heat Inactivated. | |
| MERS-CoV | Florida/USA-2_Saudi Arabia_2014 | NATMERS-ST | MERS-CoV Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | |
| Florida/USA-2_Saudi Arabia_2014 |
MERS-CoV (Strain: Florida/USA-2_Saudi Arabia_2014) Culture Fluid (1 mL)
|
BSL3 |
Live, MTA Required, BSL3 Lab Required. |
||
| Florida/USA-2_Saudi Arabia_2014 | 0810575CFHI | MERS-CoV (Strain: Florida/USA-2_Saudi Arabia_2014) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. |